Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1244 |
---|---|
Product Name | Anti-Human FLT1 Recombinant Antibody |
Molecular Name | Icrucumab |
Alias | Anti-FLT1 Recombinant Antibody, Research Grade Icrucumab |
CAS Number | 1024603-92-6 |
Target | FLT1[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Buffer | PBS, pH7.5 |
Background | Icrucumab (IMC-18F1) is a human monoclonal antibody designed for the treatment of solid tumors. Icrucumab was developed by ImClone Systems Inc. It is undergoing Phase I trials. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |